Published in Cancer Weekly, September 28th, 2004
Countries included in the agreement are Croatia, Slovenia, Bosnia and Herzegovina, Serbia, Montenegro, Macedonia, Bulgaria, Romania, Albania, and Hungary.
This agreement marks the second European distribution agreement signed by the company for its MastaScope product line and includes minimum orders, which over the course of 4 years, are expected to generate $682,000 in sales (orders specifically without replacement Mastascopes).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.